礼来)周一批准了一项至多150亿美元的股票回购计划，并将季度股息提高了15%。
受该消息影响，礼来股价盘后一度上涨1.3%。
据悉，该公司的减肥和糖尿病药物大获成功，使其成为全球市值最高的制药公司。今年以来，礼来股价累计上涨39%。
礼来早些时候宣布，在对比试验中，其减肥药物Zepbound的减重效果优于诺和诺德的Wegovy。试验显示，使用Zepbound的患者体重平均减轻20.2%，而Wegovy患者体重减轻13.7%。礼来计划将结果发表在同行评审期刊，并在医学会议上发布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.